Engelhard M - Search Results

1

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer.

Christoph DC, Kasper S, Gauler TC, Loesch C, Engelhard M, Theegarten D, Poettgen C, Hepp R, Peglow A, Loewendick H, Welter S, Stamatis G, Hirsch FR, Schuler M, Eberhardt WE, Wohlschlaeger J. Christoph DC, et al. Among authors: engelhard m. Br J Cancer. 2012 Aug 21;107(5):823-30. doi: 10.1038/bjc.2012.324. Epub 2012 Jul 26. Br J Cancer. 2012. PMID: 22836512 Free PMC article.

2

Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.

Engelhard M, Meusers P, Brittinger G, Brack N, Dornoff W, Enne W, Gassmann W, Gerhartz H, Hallek M, Heise J, et al. Engelhard M, et al. Ann Oncol. 1991 Feb;2 Suppl 2:177-80. doi: 10.1007/978-1-4899-7305-4_28. Ann Oncol. 1991. PMID: 1710919 Free article. Clinical Trial.

3

Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study.

Ho AD, Del Valle F, Engelhard M, Hiddemann W, Rückle H, Schlimok G, Haas R, Thiel E, Andreesen R, Fiedler W, et al. Ho AD, et al. Among authors: engelhard m. Cancer. 1990 Aug 1;66(3):423-30. doi: 10.1002/1097-0142(19900801)66:3<423::aid-cncr2820660304>3.0.co;2-v. Cancer. 1990. PMID: 2194641 Clinical Trial.

4

Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.

Siegert W, Nerl C, Engelhard M, Brittinger G, Tiemann M, Parwaresch R, Heinz R, Huhn D. Siegert W, et al. Among authors: engelhard m. Br J Haematol. 1994 Jul;87(3):529-34. doi: 10.1111/j.1365-2141.1994.tb08308.x. Br J Haematol. 1994. PMID: 7527646 Clinical Trial.

5

Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation.

Sak A, Grehl S, Engelhard M, Wierlemann A, Kaelberlah HP, Erichsen P, Pöttgen C, Groneberg M, Stuschke M. Sak A, et al. Among authors: engelhard m. Clin Cancer Res. 2009 Apr 15;15(8):2927-34. doi: 10.1158/1078-0432.CCR-08-0650. Epub 2009 Mar 31. Clin Cancer Res. 2009. PMID: 19336520

6

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.

Künkele A, Engelhard M, Hauffa BP, Mellies U, Müntjes C, Hüer C, Eggert A, Schulte JH, Kremens B. Künkele A, et al. Among authors: engelhard m. Pediatr Blood Cancer. 2013 Nov;60(11):1792-7. doi: 10.1002/pbc.24702. Epub 2013 Jul 24. Pediatr Blood Cancer. 2013. PMID: 23893964

7

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis.

Meusers P, Engelhard M, Bartels H, Binder T, Fülle HH, Görg K, Gunzer U, Havemann K, Kayser W, König E, et al. Meusers P, et al. Among authors: engelhard m. Hematol Oncol. 1989 Sep-Oct;7(5):365-80. doi: 10.1002/hon.2900070505. Hematol Oncol. 1989. PMID: 2670728 Clinical Trial.

8

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.

Engelhard M, Gerhartz H, Brittinger G, Engert A, Fuchs R, Geiseler B, Gerhartz D, Haunauske AR, Hartlapp HJ, Huhn D, et al. Engelhard M, et al. Ann Oncol. 1994;5 Suppl 2:123-5. doi: 10.1093/annonc/5.suppl_2.s123. Ann Oncol. 1994. PMID: 7515644 Clinical Trial.

9

Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.

Ottinger H, Belka C, Kozole G, Engelhard M, Meusers P, Paar D, Metz KA, Leder LD, Cyrus C, Gnoth S, et al. Ottinger H, et al. Among authors: engelhard m. Eur J Haematol. 1995 Mar;54(3):186-94. doi: 10.1111/j.1600-0609.1995.tb00214.x. Eur J Haematol. 1995. PMID: 7720839 Clinical Trial.

10

First experiences and perspectives for the use of cytokines in the treatment of non-Hodgkin's lymphoma.

Engelhard M. Engelhard M. Anticancer Drugs. 1993 May;4 Suppl 1:21-5. doi: 10.1097/00001813-199305001-00005. Anticancer Drugs. 1993. PMID: 8347853 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters